These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20370572)

  • 1. A new site-directed transgenic rheumatoid factor mouse model demonstrates extrafollicular class switch and plasmablast formation.
    Sweet RA; Christensen SR; Harris ML; Shupe J; Sutherland JL; Shlomchik MJ
    Autoimmunity; 2010 Dec; 43(8):607-18. PubMed ID: 20370572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites.
    Herlands RA; William J; Hershberg U; Shlomchik MJ
    Eur J Immunol; 2007 Dec; 37(12):3339-51. PubMed ID: 18034429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous loss of tolerance of autoreactive B cells in Act1-deficient rheumatoid factor transgenic mice.
    Giltiay NV; Lu Y; Cullen JL; Jørgensen TN; Shlomchik MJ; Li X
    J Immunol; 2013 Sep; 191(5):2155-63. PubMed ID: 23904159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of rheumatoid factor-specific B cells is antigen dependent and occurs preferentially outside of germinal centers in the lupus-prone NZM2410 mouse model.
    Sang A; Niu H; Cullen J; Choi SC; Zheng YY; Wang H; Shlomchik MJ; Morel L
    J Immunol; 2014 Aug; 193(4):1609-21. PubMed ID: 25015835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease.
    Hannum LG; Ni D; Haberman AM; Weigert MG; Shlomchik MJ
    J Exp Med; 1996 Oct; 184(4):1269-78. PubMed ID: 8879198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of rheumatoid factor (RF) B cells and somatic hypermutation outside of germinal centers in autoimmune-prone MRL/lpr mice.
    Shlomchik MJ; Euler CW; Christensen SC; William J
    Ann N Y Acad Sci; 2003 Apr; 987():38-50. PubMed ID: 12727622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.
    White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P
    Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination.
    Zan H; Zhang J; Ardeshna S; Xu Z; Park SR; Casali P
    Autoimmunity; 2009 Feb; 42(2):89-103. PubMed ID: 19156553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
    J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice.
    Wang H; Shlomchik MJ
    J Exp Med; 1999 Sep; 190(5):639-49. PubMed ID: 10477549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High affinity rheumatoid factor transgenic B cells are eliminated in normal mice.
    Wang H; Shlomchik MJ
    J Immunol; 1997 Aug; 159(3):1125-34. PubMed ID: 9233605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells.
    Herlands RA; Christensen SR; Sweet RA; Hershberg U; Shlomchik MJ
    Immunity; 2008 Aug; 29(2):249-60. PubMed ID: 18691914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and cellular dissection of the activation of AM14 rheumatoid factor B cells in a mouse model of lupus.
    Sang A; Zheng YY; Choi SC; Zeumer L; Morel L
    J Leukoc Biol; 2015 Aug; 98(2):209-21. PubMed ID: 25957308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoreactive B cells get activated in extrafollicular sites.
    Weisel F; Wellmann U; Winkler TH
    Eur J Immunol; 2007 Dec; 37(12):3330-3. PubMed ID: 18050163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid factor B cell memory leads to rapid, switched antibody-forming cell responses.
    Sweet RA; Cullen JL; Shlomchik MJ
    J Immunol; 2013 Mar; 190(5):1974-81. PubMed ID: 23365079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of basement membrane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus mice.
    Clark AG; Fan Q; Brady GF; Mackin KM; Coffman ED; Weston ML; Foster MH
    Autoimmunity; 2013 May; 46(3):188-204. PubMed ID: 23157336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice.
    Aït-Azzouzene D; Kono DH; Gonzalez-Quintial R; McHeyzer-Williams LJ; Lim M; Wickramarachchi D; Gerdes T; Gavin AL; Skog P; McHeyzer-Williams MG; Nemazee D; Theofilopoulos AN
    J Immunol; 2010 Jul; 185(2):1015-27. PubMed ID: 20554953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis.
    Jiang C; Zhao ML; Diaz M
    Immunology; 2009 Jan; 126(1):102-13. PubMed ID: 18624728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B and T cell tolerance and autoimmunity in autoantibody transgenic mice.
    Yan J; Mamula MJ
    Int Immunol; 2002 Aug; 14(8):963-71. PubMed ID: 12147633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of IgG autoantibody requires expression of activation-induced deaminase in early-developing B cells in a mouse model of SLE.
    Umiker BR; McDonald G; Larbi A; Medina CO; Hobeika E; Reth M; Imanishi-Kari T
    Eur J Immunol; 2014 Oct; 44(10):3093-108. PubMed ID: 25044405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.